InsiderPulseNo transactions found.
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Gross premiums written (Note 7) | $11.74B+0.0% | $11.73B+32.4% | $8.86B-3.8% | $9.21B+17.6% | $7.83B |
| Net premiums written (Note 7) | $9.87B-0.8% | $9.95B+33.3% | $7.47B+3.8% | $7.20B+21.2% | $5.94B |
| Decrease (increase) in unearned premiums | $31.0M-78.4% | $143.5M+4223.6% | $3.3M+100.4% | -$862.2M-15.7% | -$745.2M |
| Net premiums earned (Note 7) | $9.90B-1.9% | $10.10B+35.1% | $7.47B+18.0% | $6.33B+21.9% | $5.19B |
| Net investment income (Note 5) | $1.70B+3.0% | $1.65B+32.0% | $1.25B+123.8% | $559.9M+75.3% | $319.5M |
| Net foreign exchange gains (losses) | -$13.5M+82.2% | -$76.1M-83.4% | -$41.5M+27.1% | -$56.9M-38.8% | -$41.0M |
| Equity in earnings (losses) of other ventures (Note 5) | $71.3M+51.5% | $47.1M+8.3% | $43.5M+286.5% | $11.2M-8.6% | $12.3M |
| Other income (loss) | $4.3M+124.1% | $1.9M+131.3% | -$6.2M-148.7% | $12.6M+16.1% | $10.9M |
| Net realized and unrealized gains (losses) on investments | $1.18B+4343.1% | -$27.8M-106.7% | $414.5M+123.0% | -$1.80B-725.4% | -$218.1M |
| Total revenues | $12.85B+9.9% | $11.70B+28.0% | $9.13B+80.5% | $5.06B-4.1% | $5.28B |
| Net claims and claim expenses incurred (Notes 7 and 8) | $5.62B+5.3% | $5.33B+49.2% | $3.57B-17.6% | $4.34B+11.9% | $3.88B |
| Acquisition expenses | $2.55B-3.5% | $2.64B+41.0% | $1.88B+19.5% | $1.57B+29.1% | $1.21B |
| Operational expenses | $464.5M-6.5% | $496.6M+32.4% | $375.2M+35.6% | $276.7M+30.4% | $212.2M |
| Corporate expenses | $82.0M-39.2% | $134.8M+5.6% | $127.6M+172.9% | $46.8M+13.7% | $41.2M |
| Interest expense (Note 9) | $120.9M+28.9% | $93.8M+28.1% | $73.2M+51.4% | $48.3M+1.7% | $47.5M |
| Total expenses | $8.83B+1.5% | $8.70B+44.4% | $6.02B-4.1% | $6.28B+16.5% | $5.39B |
| Income (loss) before taxes | $4.01B+34.1% | $2.99B-3.8% | $3.11B+355.2% | -$1.22B-968.1% | -$114.1M |
| Income tax benefit (expense) (Note 15) | -$396.3M-1114.7% | -$32.6M-106.4% | $510.1M+764.2% | $59.0M+453.2% | $10.7M |
| Net income (loss) | $3.62B+22.2% | $2.96B-18.2% | $3.62B+412.1% | -$1.16B-1021.2% | -$103.4M |
| Net (income) loss attributable to redeemable noncontrolling interests (Note 10) | -$935.4M+14.2% | -$1.09B-2.9% | -$1.06B-1173.9% | $98.6M+55.8% | $63.3M |
| Net income (loss) attributable to RenaissanceRe | $2.68B+43.4% | $1.87B-27.0% | $2.56B+341.3% | -$1.06B-2542.8% | -$40.2M |
| Dividends on preference shares (Note 12) | -$35.4M+0.0% | -$35.4M+0.0% | -$35.4M+0.0% | -$35.4M-6.3% | -$33.3M |
| Net income (loss) available (attributable) to RenaissanceRe common shareholders | $2.65B+44.2% | $1.83B-27.3% | $2.53B+330.3% | -$1.10B-1393.5% | -$73.4M |
| Net income (loss) available (attributable) to RenaissanceRe common shareholders per common share – basic (in dollars per share) | $56K+59.2% | $35K-32.6% | $52K+305.5% | -$26K | — |
| Net income (loss) available (attributable) to RenaissanceRe common shareholders per common share – diluted (in dollars per share) | $56K+59.1% | $35K-32.6% | $52K+305.0% | -$26K | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
RenaissanceRe Holdings Ltd. Announces Board of Directors Changes, Declares Quarterly Dividend and Approves Renewal of Share Repurchase Program
Will Higher Costs Hurt Skyward Specialty's Q1 Earnings?
CNO Beats Q1 Earnings Estimates on Higher Life and Health Premiums
VIRT Beats Q1 Earnings Estimates on Execution Services Unit Strength